EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases

Jialian Lv, Xinyue Song, Zixin Luo, Duoqin Huang, Li Xiao, Kang Zou

Frontiers in Pharmacology · 12.02.2025 · 16

DOI: 10.3389/fphar.2025.1535555 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 12.02.2025. Verfasst von Jialian Lv und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Luteolin is a flavonoid widely found in plants, including vegetables, botanical drugs, and fruits. Owing to its diverse pharmacological activities, such as anticancer, oxidative stress protection, anti-inflammatory, and neuron-preserving effects, luteolin has attracted attention in research and medicine. Luteolin exhibits therapeutic effects on various pulmonary disease models through multiple molecular mechanisms; these include inhibition of activation of the PI3K/Akt-mediated Nuclear Factor kappa-B (NF-κB) and MAPK signaling pathways, as well as the promotion of regulatory T cell (Treg) function and enhancement of alveolar epithelial sodium channel (ENaC) activity (alleviating inflammation and oxidative stress responses). Luteolin has therapeutic effects on chronic obstructive pulmonary disease (COPD), acute lung injury/acute respiratory distress syndrome (ALI/ARDS), pulmonary fibrosis, allergic asthma, and lung cancer. Luteolin, a naturally occurring polyphenol, is poorly water-soluble. The oral route may be ineffective because the gut poorly absorbs this type of flavonoid. Therefore, although luteolin exhibits significant biological activity, its clinical application is limited by challenges associated with its poor water solubility and low bioavailability, which are critical factors for its efficacy and pharmacological application. These challenges can be addressed by modifying the chemical structure and enhancing pharmaceutical formulations. We summarized the research advancements in improving the solubility and bioavailability of luteolin, as well as the effects of luteolin on various pulmonary diseases and their related mechanisms, with the aim of providing new ideas for researchers.

Schlagwörter

Stichwörter der Autor:innen

bioavailabilityluteolinmolecular mechanismspharmacokineticspharmacological activitiespulmonary diseases

Autor:innen und Institutionen

  • The First Clinical Medical College, Gannan Medical University, Ganzhou, Jiangxi, China.
  • Department of Rehabilitation Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
  • Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.

Zitieren

APA

Lv, J., Song, X., Luo, Z., Huang, D., Xiao, L., & Zou, K. (2025). Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1535555

Vancouver

Lv J, Song X, Luo Z, Huang D, Xiao L, Zou K. Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1535555

BibTeX
@article{Lv2025,
  author = {Lv, Jialian and Song, Xinyue and Luo, Zixin and Huang, Duoqin and Xiao, Li and Zou, Kang},
  title = {Luteolin: exploring its therapeutic potential and molecular mechanisms in pulmonary diseases},
  journal = {Frontiers in Pharmacology},
  year = {2025},
  volume = {16},
  doi = {10.3389/fphar.2025.1535555}
}
Kostenlos starten →